Description
Recombinant monoclonal antibody to CD21L. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma R4/23.
Target
CD21L
Target Alias Names
Complement receptor type 2, CR2, Complement C3d receptor, Epstein-Barr virus receptor, EBV receptor, CD21
Isotype/Mimetic
IgM
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression